These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 668875)
1. [Kinetics of accumulation and elimination of 14C-dipine, an antineoplastic drug]. Korolev GK; Kurasova VG; Kurchatova VV Farmakol Toksikol; 1978; 41(4):473-80. PubMed ID: 668875 [TBL] [Abstract][Full Text] [Related]
2. [Study of the pharmacokinetics of phosphemide in rats with the use of physico-chemical methods]. Safonova TS; Presnova ZhF; Linberg LF; Chernov VA; Kuriatov NS Farmakol Toksikol; 1975; 38(4):491-4. PubMed ID: 1213145 [TBL] [Abstract][Full Text] [Related]
3. [The kinetics of accumulation and elimination of the antitumor preparation tomizine-35 S]. Korolev GK Vopr Onkol; 1975; 21(11):50-6. PubMed ID: 1210119 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of the antineoplastic agent 14C-prospidin in rats according to distribution data of the radioactive label]. Korolev GK; Kurasova VG Farmakol Toksikol; 1981; 44(6):714-8. PubMed ID: 7308454 [TBL] [Abstract][Full Text] [Related]
5. [Prospidin-C14 blood level, distribution in the organs and tissues and excretion from the body of rats]. Bogomolova NS; Suskova VS; Minakova SM; Chernov VA; Serebriakov NG Farmakol Toksikol; 1975; 38(6):722-8. PubMed ID: 1227923 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration. Okuyama Y; Momota K; Morino A Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats. Siefert HM; Maruhn D; Scholl H Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707 [TBL] [Abstract][Full Text] [Related]
8. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986). Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of P32-phosphemide in the body of rats with sarcoma 45]. Filatov PP; Vatin AE; Averina SA; Savin IuI Farmakol Toksikol; 1976; 39(5):598-600. PubMed ID: 1028587 [TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of 14C-activity after the administration of 14C-azimexone in rats. Wölfel B; Hartung K; Haak A; Kaufmann B; Koch K; Abshagen U Int J Immunopharmacol; 1981; 3(2):133-40. PubMed ID: 7196389 [TBL] [Abstract][Full Text] [Related]
12. Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat. Setnikar I; Giachetti C; Zanolo G Pharmatherapeutica; 1984; 3(8):538-50. PubMed ID: 6422479 [TBL] [Abstract][Full Text] [Related]
13. Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen. Kobayashi S; Kyui S; Yoshida T; Nagakura A; Oiwa Y; Matsumura R; Kohei H Arzneimittelforschung; 1981; 31(4):679-90. PubMed ID: 6894697 [TBL] [Abstract][Full Text] [Related]
14. [Metabolism of the antineoplastic agent N-pyrimidly-2N1, N2-di-(ethylene)-triamide phosphate (fosfemid)]. Safonova TS; Linberg LF; Presnova ZhF; Kuriatov NS; Chernov VA Dokl Akad Nauk SSSR; 1974; 219(5):1271-2. PubMed ID: 4442341 [No Abstract] [Full Text] [Related]
15. [The pharmacokinetics of 14C-zolimidine in rats]. Schraven E; Trottnow D Arzneimittelforschung; 1976 Feb; 26(2):213-8. PubMed ID: 947201 [TBL] [Abstract][Full Text] [Related]
16. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of diaziquone after three different dosage regimens. Bjornsson TD; Schold SC; Friedman HS; Schneider D; Falletta JM Cancer Treat Rep; 1985 Dec; 69(12):1383-5. PubMed ID: 4075314 [TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
19. Absorption, distribution and excretion of [14C]-Lesopitron after single and repeated administration in rats and dogs. Serafini MT; Puig S; García-Encina G; Farran R; García-Soret A; Moragon T; Martínez L Methods Find Exp Clin Pharmacol; 1997; 19(1):61-72. PubMed ID: 9098842 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic characteristics of 14C-peritol based on data on its distribution in rat tissue]. Dedenkov AN; Korolev GK; Kurchatova VV; Romantsova VA Farmakol Toksikol; 1981; 44(4):443-6. PubMed ID: 7286203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]